First patients test promising new pill for Tough-to-Treat lymphoma
NCT ID NCT06470438
Summary
This is the first study in people testing a new oral medication called JNJ-88998377 for patients with B-cell non-Hodgkin's lymphoma that has returned or not responded to other treatments. The main goals are to check the drug's safety and figure out the best dose for future testing. The study will enroll about 58 participants who have exhausted other treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED B-CELL NHL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
A O U Sant Orsola Malpighi
Bologna, 40138, Italy
-
Aidport Sp z o o
Skorzewo, 60-185, Poland
-
Ankara Universitesi Hastaneleri Tibbi Farmakoloji Anabilim Dali Faz 1 Klinik Arastirma Merkezi
Ankara, 06620, Turkey (Türkiye)
-
Beijing Cancer Hospital
Beijing, 100142, China
-
Fudan University Shanghai Cancer Center
Shanghai, 200032, China
-
Koc Universitesi Hastanesi Faz 1 Klinik Arastirma Merkezi
Istanbul, 34010, Turkey (Türkiye)
-
Linkou Chang Gung Memorial Hospital
Taoyuan District, 33382, Taiwan
-
National Cancer Center Hospital
Chūōku, 104 0045, Japan
-
National Cancer Center Hospital East
Kashiwa, 277-8577, Japan
-
National Taiwan University Hospital
Taipei, 10043, Taiwan
-
Pratia Onkologia Katowice
Katowice, 40 519, Poland
-
SBU Ankara Dr. Abdurrahman Yurtaslan Onkoloji Egitim ve Arastirma Hastanesi Faz 1 Merkezi
Ankara, 06200, Turkey (Türkiye)
-
Samsung Medical Center
Seoul, 06351, South Korea
-
Seoul National University Hospital
Seoul, 03080, South Korea
-
Sun Yat Sen University Cancer Center
Guangzhou, 510062, China
-
Swietokrzyskie Centrum Onkologii SPZOZ w Kielcach, Klinika Hematologii i Transplantacji Szpiku
Kielce, 25-734, Poland
-
The Cancer Institute Hospital of JFCR
Tokyo, 135 8550, Japan
-
The First Affiliated Hospital Zhejiang University College of Medicine
Hangzhou, 310002, China
-
Tianjin Medical University Cancer Institute and Hospital
Tianjin, 300181, China
Conditions
Explore the condition pages connected to this study.